Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Eustachian tube mucosa air-liquid interface (ALI) is a specialized biological model used to study the respiratory-type epithelium that lines the Eustachian tube (Kerschner et al., 2007). In this system, epithelial cells are cultured on a permeable membrane where the apical surface is exposed to air while the basolateral surface remains in contact with nutrient-rich media, mimicking the physiological environment of the human airway (Qin et al., 2020). This setup is crucial for the differentiation of the mucosa into a functional pseudostratified epithelium containing ciliated cells and mucus-secreting goblet cells. The ET-ALI model is primarily utilized in research to investigate the pathogenesis of otitis media and Eustachian tube dysfunction, particularly how the mucosal barrier responds to bacterial and viral infections (Jung et al., 2021). While it is not a molecular target for drug action, it serves as a vital tool for evaluating the efficacy and toxicity of intranasal or transtympanic pharmacological interventions, such as corticosteroids. By measuring parameters such as ciliary beat frequency and transepithelial electrical resistance, researchers can assess the impact of drugs on mucociliary clearance and barrier integrity. This model bridges the gap between traditional 2D cell cultures and in vivo animal models, providing a more accurate representation of human Eustachian tube physiology.
Not applicable as this is a biological model/tissue system rather than a molecular target. It is used to evaluate drug effects on mucociliary clearance and barrier integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eustachian tube mucosa air-liquid interface (ET-ALI).